DOI QR코드

DOI QR Code

Explanation and Elaboration of the Clinical Trial Guidelines for Psoriasis Using Herbal Medicine

건선 치료용 한약제제에 대한 임상시험 가이드라인 설명 및 제언

  • Kim, Bong-Hyun (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Kim, Kwan-Il (Division of Allergy, Immune & Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Kang, Se-Hyun (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Park, Jung-Gun (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Kang, Dong-Won (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Nam, Hae-Jeong (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Kim, Yoon-Bum (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Lee, Jun-Hee (Korean Medicine Clinical Trial Center, Kyung Hee University Korean Medicine Hospital) ;
  • Kim, Kyu-Seok (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, College of Korean Medicine, Kyung Hee University)
  • 김봉현 (경희대학교 한의과대학 안이비인후피부과) ;
  • 김관일 (경희대학교 한의과대학 폐계내과학교실) ;
  • 강세현 (경희대학교 한의과대학 안이비인후피부과) ;
  • 박중군 (경희대학교 한의과대학 안이비인후피부과) ;
  • 강동원 (경희대학교 한의과대학 안이비인후피부과) ;
  • 남혜정 (경희대학교 한의과대학 안이비인후피부과) ;
  • 김윤범 (경희대학교 한의과대학 안이비인후피부과) ;
  • 이준희 (경희대학교한방병원 한의약임상시험센터) ;
  • 김규석 (경희대학교 한의과대학 안이비인후피부과)
  • Received : 2018.04.06
  • Accepted : 2018.05.01
  • Published : 2018.05.25

Abstract

Objectives : We report on the contents and reviews of the guidelines for clinical trials of herbal medicine for psoriasis. Methods : After reviewing the existing reports, the guidelines were drafted by the writing committee on guidelines for Korean medicine clinical trial center in Kyung Hee university Korean medicine hospital. Since then, the guidelines have been consulted by the experts in diseases, clinical trials and pharmaceuticals. In addition, the guidelines have been certified by the Korean medicine clinical trial center association and Korean Medicine Ophthalmology & Otolaryngology & Dermatology Society. Results : The guidelines for clinical trials are divided into 8 categories: (1) general contents, (2) evaluation standards of effectiveness, (3) outcome valuables, (4) selection of study participants, (5) designs of clinical trials, (6) safety evaluations, (7) combination therapies in psoriasis treatment and (8) Korean medical considerations. Conclusions : There are 3 major contents for discussion: (1) obscurity of Korean medical considerations to differentiate from existing guidelines, (2) the absence of Korean version of PASI and DLQI, which are validity parameters and (3) realistic institutional problem using the herbal medicine.

Keywords

References

  1. Kang H, Kang HY, Koo DW, Kwon O, Kim GM, Kim KJ, et al. Textbook of Dermatology. 6th ed. Seoul:Medbook. 2014:299.
  2. Christophers E. Psoriasis--epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26(4):314-20. https://doi.org/10.1046/j.1365-2230.2001.00832.x
  3. Boehncke WH, Schon MP. Psoriasis. Lancet. 2015;386(9997):983-94. https://doi.org/10.1016/S0140-6736(14)61909-7
  4. Kang SH, Moon YK, Jeong WY, Nam HJ, Kim YB, Lee JH, et al. Comparison between domestic and foreign clinical guidelines and previous researches on Korean medicine for psoriasis to develop the clinical trial guideline of psoriasis using Korean medicine. J Korean Med Ophthalmol Otolaryngol Dermatol. 2016;29(2):12-32. https://doi.org/10.6114/jkood.2016.29.2.012
  5. Bozek A, Reich A. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment. Adv Clin Exp Med. 2017;26(5):853.
  6. He J, Du L, Liu G, Fu J, He X, Yu J, et al. Quality assessment of reporting of randomization, allocation, concealment and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews. Trials. 2011;12:122. https://doi.org/10.1186/1745-6215-12-122
  7. Cheng CW, Wu TX, Shang HC, Li YP, Altman DG, Moher D, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation and Elaboration. Ann Intern Med. 2017;167(2):112. https://doi.org/10.7326/M16-2977
  8. Korea Institute of Oriental Medicine. Preferred Reporting Items for Development of Clinical Practice Guideline in Korean Medicine. Seoul:Elsevier Korea L.L.C. 2015:12-4,106-7.
  9. Jeong SY. The Clinical trial Guideline of the new medicine and Traditional chinese medicine. Chinese Medicine and science press. 2002;1:299-302.
  10. Seo HS, Yoon HJ, Ko WS, Kim KJ, Kim NK, Kim YB, et al. Text of Traditional Korean Dermatology & Surgery. 1st ed. Busan:SunWo. 2007:381-6.
  11. Ministry of Health and Welfare. Minor revisions to the application criteria and methods of medical care benefits (2018-28) [Appendix 2]. Notice of Ministry of Health and Welfare. 2018:1-26. Available from: URL:http://www.mohw.go.kr/react/jb/sjb0406vw.jsp
  12. Sung YH, Kim HJ, Koh SB, Kim JS, Kim SJ, Cheon SM, et al. Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep. J Korean Med Sci. 2018;33(2):1-9. https://doi.org/10.3904/kjim.2017.377
  13. Youn SW. The Assessment of Psoriasis Severity: PASI, BSA, DLQI. J Korean Soc for Psoriasis. 2013;10(1):11-4.

Cited by

  1. 건선에 효과적인 한약 처방 탐색 - 지질 대사를 중심으로 vol.34, pp.3, 2018, https://doi.org/10.6114/jkood.2021.34.3.070